Johnson & Johnson to acquire Momenta Pharmaceuticals for 6.5B


The companies are expected to complete the transaction in the second half of this year, pending the satisfaction of all conditions to the completion of the tender offer and merger.

Janssen plans to maintain Momenta’s presence in Cambridge, Massachusetts.


Signup for the USA Herald exclusive Newsletter

Have a story you want USA Herald to cover? Submit a tip here and if we think it’s newsworthy, we’ll follow up on it.

Want guaranteed coverage? We also offer contract journalism here.  Just be sure you’re comfortable giving up editorial control because our journalists are dogged and will follow the story through to the conclusion. The story will be published to our exacting standards, without regard for your preferred slant.

Want to contribute a story? We also accept article submissions — check out our writer’s guidelines here.